Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi The modern management of ovarian cancer
Benedict B Benigno
Northside Hospital, USA
: J Nurs Patient Care
Abstract
Ovarian cancer always presents in advanced stages, requires extensive surgery and chemotherapy, and is accompanied by an unacceptably high recurrence rate. Carboplatinum and Taxol have been the drugs of choice in first-line therapy for over 30 years and, unfortunately, the survival rate has enjoyed slight improvement during this time period. I will discuss this disease within its historic perspective and elucidate the evolution of modern surgical techniques and various chemotherapy regimens. I will go into considerable detail regarding both clinical and basic research which have led to newer, and hopefully better, treatment modalities. I will use case studies from my extensive experience in treating patients with ovarian cancer, to explore ways in which the patient-physician relationship itself might become an instrument of healing. I will conclude by describing and exciting and recently available class of drugs – the PARP inhibitors.
Biography
Benedict B Benigno is a world-renowned Gynaecologic Surgeon and Oncologist who has spent his career treating women with ovarian cancer. He received his MD degree from the Georgetown University School of Medicine, and completed his residency in Obstetrics and Gynecology at St. Vincent’s Hospital and Medical Center in New York City. He completed two fellowships in Gynaecologic Oncology, one at the Emory University School of Medicine in Atlanta and the other at the MD Anderson Hospital and Tumor Institute in Houston. He is the Founder and President of University Gynecologic Oncology and the Director of Gynaecologic Oncology at Northside Hospital in Atlanta, Georgia. He is a member of many societies including the Society of Gynecologic Oncologists, the Felix Rutledge Society, and the American Society of Clinical Oncologists. He has published numerous articles and textbook chapters, and travels the world speaking on various aspects of gynaecologic cancer.
